Impairment of IFN-&alpha; production capacity in patients with hepatitis C virus and the risk of the development of hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

187

HTML

2187

Figures (1-2)

166

Tables (1-2)

147

Sum=2687

Dec 14, 2005 (publication date) through Apr 30, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 14, 2005; 11(46): 7330-7334
Published online Dec 14, 2005. doi: 10.3748/wjg.v11.i46.7330

Figure 1 IFN-α production capacity per 1 000 WBC in patients with persistent HCV infection in various stages.

Figure 2 IFN-α production capacity per 1 000 WBC and duration of HCV infection.

Citation: Uno K, Suginoshita Y, Kakimi K, Moriyasu F, Hirosaki M, Shirakawa T, Kishida T. Impairment of IFN-α production capacity in patients with hepatitis C virus and the risk of the development of hepatocellular carcinoma. World J Gastroenterol 2005; 11(46): 7330-7334
URL: https://www.wjgnet.com/1007-9327/full/v11/i46/7330.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i46.7330